Easterly Investment Partners LLC Biogen Inc. Transaction History

Easterly Investment Partners LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$212.02 - $267.71 $7.81 Million - $9.87 Million	36,858 Added 724.98%	41,942 $9.04 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $395,765 - $476,397	-1,778 Reduced 25.91%	5,084 $1.32 Million
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $6,839 - $7,719	-27 Reduced 0.39%	6,862 $1.76 Million
Q1 2023 Nov 13, 2023	BUY	$256.56 - $292.34 $24,629 - $28,064	96 Added 1.41%	6,889 $1.92 Million
Q1 2023 May 02, 2023	BUY	$256.56 - $292.34 $145,726 - $166,049	568 Added 8.6%	7,173 $1.99 Million
Q4 2022 Nov 13, 2023	SELL	$252.44 - $306.72 $95,927 - $116,553	-380 Reduced 5.3%	6,793 $1.88 Million
Q4 2022 Feb 10, 2023	BUY	$252.44 - $306.72 $456,159 - $554,243	1,807 Added 37.66%	6,605 $1.83 Million
Q3 2022 Nov 09, 2022	SELL	$194.69 - $268.46 $259,716 - $358,125	-1,334 Reduced 21.75%	4,798 $1.28 Million
Q2 2022 Aug 10, 2022	SELL	$187.54 - $223.02 $1.64 Million - $1.95 Million	-8,728 Reduced 58.73%	6,132 $1.25 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $3.03 Million - $3.82 Million	-15,635 Reduced 51.27%	14,860 $3.13 Million
Q4 2021 Aug 02, 2022	BUY	$223.92 - $287.77 $1.75 Million - $2.24 Million	7,793 Added 34.33%	30,495 $7.32 Million
Q4 2021 Feb 08, 2022	BUY	$223.92 - $287.77 $4.32 Million - $5.55 Million	19,293 Added 565.94%	22,702 $5.45 Million
Q3 2021 Nov 16, 2021	BUY	$282.99 - $369.05 $8.91 Million - $11.6 Million	31,471 New	31,471 $8.91 Million
Q2 2021 Jul 26, 2021	BUY	$259.0 - $414.71 $882,931 - $1.41 Million	3,409 New	3,409 $1.18 Million

1,050

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $27.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Easterly Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Easterly Investment Partners LLC with notifications on news.